tiprankstipranks
Advertisement
Advertisement
ReShape announces shareholder approval of Vyome merger
PremiumThe FlyReShape announces shareholder approval of Vyome merger
8M ago
ReShape Lifesciences Holds Special Stockholder Meeting
Premium
Company Announcements
ReShape Lifesciences Holds Special Stockholder Meeting
8M ago
ReShape Lifesciences Announces Merger with Vyome Therapeutics
Premium
Company Announcements
ReShape Lifesciences Announces Merger with Vyome Therapeutics
9M ago
ReShape Lifesciences granted key international patent in Australia
PremiumThe FlyReShape Lifesciences granted key international patent in Australia
9M ago
ReShape Lifesciences Raises Equity to Avoid Delisting
Premium
Company Announcements
ReShape Lifesciences Raises Equity to Avoid Delisting
9M ago
ReShape Lifesciences Closes $2.6M Stock Offering
Premium
Company Announcements
ReShape Lifesciences Closes $2.6M Stock Offering
10M ago
ReShape Lifesciences prices 1.054M shares at $2.50 in public offering
PremiumThe FlyReShape Lifesciences prices 1.054M shares at $2.50 in public offering
10M ago
ReShape Lifesciences announces EU MDR certification for European, UK portfolio
Premium
The Fly
ReShape Lifesciences announces EU MDR certification for European, UK portfolio
10M ago
ReShape Lifesciences Faces Nasdaq Delisting Notice
Premium
Company Announcements
ReShape Lifesciences Faces Nasdaq Delisting Notice
10M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100